Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Insulin Detemir Combo with Sitagliptin and Metformin Efficacy & Safety Posted: Sunday, February 06, 2011

Detemir plus sitagliptin more effective than sitagliptin with metformin with or without a sulfonylurea.

A Systematic Review of Newer Drugs for Glucose Control Posted: Sunday, February 06, 2011

The National Institute for Health and Clinical Excellence (NICE) issued an updated Guideline for newer drugs for the management of all aspects of Type 2 diabetes. The guidelines review the newer agents from four classes with a cost analysis.

For Those 60 Percent of Type 2 Patients Who Are Not in Control Posted: Saturday, January 29, 2011

Consider a GLP-1 plus a long-acting insulin.

Why Don't People Take Their Insulin as Prescribed? Posted: Sunday, January 23, 2011

Risk factors differed between Type 1 and Type 2 diabetic patients, with diet nonadherence more prominent in Type 1 diabetes.

Race/Ethnicity Plays A Role in the Efficacy of Insulin Regimens Posted: Sunday, January 23, 2011

Latino/Hispanic, Asian, and African-descent patients with Type 2 diabetes show different metabolic responses to insulin therapy, dependent in part on insulin type and regimen intensity.

Combining Exenatide with Insulin May Be 'Best Result Ever' for Diabetes Patients Posted: Tuesday, December 21, 2010

Combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with Type 2 diabetes than insulin alone and helps promote weight loss.

Brain Key to Leptin's Actions against Type 1 Diabetes Posted: Wednesday, November 03, 2010

New findings by UT Southwestern Medical Center researchers suggest a novel role for the brain in mediating beneficial actions of the hormone leptin in Type 1 diabetes.

Resistance Exercise Lowers Need for Insulin in GDM Posted: Wednesday, November 03, 2010

Resistance exercise (RE) may lower the need for insulin in gestational diabetes mellitus (GDM), according to the results of a randomized controlled trial.

EASD: Adding Incretin to Insulin Lowers HbA1c Posted: Sunday, October 03, 2010

Adding exenatide to insulin glargine for patients who aren't fully controlled with insulin glargine and/or other oral agents can help to improve their blood glucose.

FDA & CDC WARNING: Limit Fingerstick Devices to Just One Patient Posted: Tuesday, September 14, 2010

Fingerstick devices along with insulin pens should never be used with more than one person.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.